AAAAAA

   
Results: 1-12 |
Results: 12
Prostaglandins and lipid modification
Authors: Sobal, G Sinzinger, H
Citation: G. Sobal et H. Sinzinger, Prostaglandins and lipid modification, CUR PHARM D, 7(6), 2001, pp. 461-474
Methylene blue-enhanced stability of (Tc-99m)HMPAO and simplified quality control - a comparative investigation
Authors: Sobal, G Sinzinger, H
Citation: G. Sobal et H. Sinzinger, Methylene blue-enhanced stability of (Tc-99m)HMPAO and simplified quality control - a comparative investigation, APPL RAD IS, 54(4), 2001, pp. 633-636
Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation
Authors: Sobal, G Menzel, EJ Sinzinger, H
Citation: G. Sobal et al., Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation, BIOCH PHARM, 61(3), 2001, pp. 373-379
The role of antioxidants in the long-term glycation of low density lipoprotein and its Cu2+-catalyzed oxidation
Authors: Sobal, G Menzel, J
Citation: G. Sobal et J. Menzel, The role of antioxidants in the long-term glycation of low density lipoprotein and its Cu2+-catalyzed oxidation, FREE RAD RE, 32(5), 2000, pp. 439-449
Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study
Authors: Sobal, G Menzel, J Sinzinger, H
Citation: G. Sobal et al., Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study, PROS LEUK E, 63(4), 2000, pp. 177-186
The effects of glycation/glycoxidation on the liberation of 8-epi-PGF(2 alpha) from low density lipoprotein during its in vitro oxidation
Authors: Sobal, G Menzel, EJ Sinzinger, H
Citation: G. Sobal et al., The effects of glycation/glycoxidation on the liberation of 8-epi-PGF(2 alpha) from low density lipoprotein during its in vitro oxidation, PROS LEUK E, 62(4), 2000, pp. 217-224
Troglitazone-binding to Ldl and its glycated modifications - Its role in cell-catalysed and Cu-mediated Ldl-oxidation
Authors: Sobal, G Sinzinger, H Menzel, EJ
Citation: G. Sobal et al., Troglitazone-binding to Ldl and its glycated modifications - Its role in cell-catalysed and Cu-mediated Ldl-oxidation, LIFE SCI, 67(6), 2000, pp. 695-707
Influence of acetylsalicylic acid on oxidation of native and glycated low-density lipoprotein
Authors: Sobal, G Menzel, JE Sinzinger, H
Citation: G. Sobal et al., Influence of acetylsalicylic acid on oxidation of native and glycated low-density lipoprotein, LIFE SCI, 66(20), 2000, pp. 1987-1998
Changes of biochemical and biomechanical properties in dupuytren disease
Authors: Melling, M Karimian-Teherani, D Mostler, S Behnam, M Sobal, G Menzel, EJ
Citation: M. Melling et al., Changes of biochemical and biomechanical properties in dupuytren disease, ARCH PATH L, 124(9), 2000, pp. 1275-1281
Differential scanning calorimetry, biochemical, and biomechanical analysisof human skin from individuals with diabetes mellitus
Authors: Melling, M Pfeiler, W Karimian-Teherani, D Schnallinger, M Sobal, G Zangerle, C Menzel, EJ
Citation: M. Melling et al., Differential scanning calorimetry, biochemical, and biomechanical analysisof human skin from individuals with diabetes mellitus, ANAT REC, 259(3), 2000, pp. 327-333
Binding of long-term glycated low density lipoprotein and age- albumin by peripheral monocytes and endothelial cells
Authors: Sobal, G Sinzinger, H Menzel, EJ
Citation: G. Sobal et al., Binding of long-term glycated low density lipoprotein and age- albumin by peripheral monocytes and endothelial cells, J RECEPT SI, 19(1-4), 1999, pp. 267-281
Effects of PGI(2) and analogues (taprostene, iloprost) on oxidation of native and glycated LDL
Authors: Sobal, G Sinzinger, H
Citation: G. Sobal et H. Sinzinger, Effects of PGI(2) and analogues (taprostene, iloprost) on oxidation of native and glycated LDL, LIFE SCI, 65(12), 1999, pp. 1237-1246
Risultati: 1-12 |